SpaceX is set to go public on Nasdaq under the ticker SPCX with shares priced at $135 each, valuing the company at nearly $1.75 trillion. This IPO is prompting investors to raise cash, which is temporarily affecting other tech stocks negatively. Fundstrat's Thomas Lee expects this dip to reverse after the SpaceX IPO. The event is significant as it marks one of the largest market debuts, influencing broader market dynamics.
Ascendis Pharma reported positive five-year results from its Phase 2 PaTH Forward trial of TransCon PTH (palopegteriparatide) for adult hypoparathyroidism. The therapy maintained stable calcium levels, kidney and bone health, and quality of life, all...
SpaceX began trading on the stock market at $150 per share, above its IPO price of $135, marking the largest public offering in history and valuing the company at about $1.96 trillion. The shares quickly rose to $165, reflecting strong demand that ex...
Space ETFs fell significantly on the day SpaceX launched its IPO, priced at $135 per share with a $1.77 trillion valuation, raising $75 billion in the largest IPO ever. The sell-off reflects investors rotating out of other space stocks to buy SpaceX ...
Park Ha Biological Technology announced a strategic partnership with Star Plus Action to integrate AI technology into skincare and healthcare services. This collaboration aims to create an intelligent service ecosystem in the beauty and wellness indu...
LIXTE Biotechnology Holdings is acquiring NOMAD Transportable Power Systems to become NOMAD Power Solutions, focusing on rapid deployment of utility-grade battery storage to address US power delivery delays. With grid interconnection delays stretchin...
